Updated Prevalence of Lymphangioleiomyomatosis in Europe
Top Cited Papers
- 15 February 2024
- journal article
- letter
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 209 (4) , 456-459
Abstract
No abstract availableKeywords
Funding Information
- HRB Ireland (CTN-2021-009)
- LAM Foundation (LAM0144SG01-20)
- HRB Ireland (CTN-2021-009)
- LAM Foundation (LAM0144SG01-20)
This publication has 18 references indexed in Scilit:
- Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus ConferencePediatric Neurology, 2013
- Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trialThe Lancet Respiratory Medicine, 2013
- Lymphangioleiomyomatosis Screening in Women With Tuberous SclerosisChest, 2013
- Lymphangioleiomyomatosis: Calling It What It Is: A Low-Grade, Destructive, Metastasizing NeoplasmAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Lymphangioleiomyomatosis — a wolf in sheep’s clothingJournal of Clinical Investigation, 2012
- Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosisQJM: An International Journal of Medicine, 2011
- European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosisEuropean Respiratory Journal, 2009
- Diagnostic Potential of Serum VEGF-D for LymphangioleiomyomatosisNew England Journal of Medicine, 2008
- The NHLBI Lymphangioleiomyomatosis RegistryAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Prevalence and Clinical Characteristics of Lymphangioleiomyomatosis (LAM) in Patients with Tuberous Sclerosis ComplexAmerican Journal of Respiratory and Critical Care Medicine, 2001